Search Results - "Cross, James T."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Risperidone-Associated Diabetes Mellitus: A Pharmacovigilance Study by Koller, Elizabeth A., Cross, James T., Doraiswamy, P. Murali, Schneider, Bruce S.

    Published in Pharmacotherapy (01-06-2003)
    “…Study Objective. To explore the clinical characteristics of hyperglycemia in patients treated with risperidone. Design. Pharmacovigilance survey of…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetics and clinical effectiveness of methylphenidate by KIMKO, H. C, CROSS, J. T, ABERNETHY, D. R

    Published in Clinical pharmacokinetics (01-12-1999)
    “…Methylphenidate is prescribed for over 90% of children in the US diagnosed as having attention-deficit hyperactivity disorder (ADHD). Although ADHD has been…”
    Get full text
    Journal Article
  3. 3

    Pancreatitis Associated with Atypical Antipsychotics: From the Food and Drug Administration's MedWatch Surveillance System and Published Reports by Koller, Elizabeth A., Cross, James T., Doraiswamy, P. Murali, Malozowski, Saul N.

    Published in Pharmacotherapy (01-09-2003)
    “…Study Objective. To investigate the relative numbers and clinical characteristics of pancreatitis in patients treated with the atypical antipsychotic agents,…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    A review of gene-drug interactions for non-steroidal anti-inflammatory drug (NSAID) use in preventing colorectal neoplasia by Cross, James T., Poole, Elizabeth M., Ulrich, Cornelia M.

    Published in The pharmacogenomics journal (15-01-2008)
    “…Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to be effective chemopreventive agents for colorectal neoplasia. Polymorphisms in NSAID targets…”
    Get full text
    Journal Article
  7. 7

    Novel quantitative methods for drug benefit-risk assessment in regulatory decision-making: A case study and policy analysis by Cross, James T

    Published 01-01-2009
    “…The United States Food and Drug Administration and European Medicines Agency are evaluating quantitative methods for assessing the benefits and risks of…”
    Get full text
    Dissertation
  8. 8

    Novel quantitative methods for drug benefit-risk assessment in regulatory decision-making: A case study and policy analysis by Cross, James T

    “…The United States Food and Drug Administration and European Medicines Agency are evaluating quantitative methods for assessing the benefits and risks of…”
    Get full text
    Dissertation
  9. 9
  10. 10
  11. 11
  12. 12

    In the Gaussian integers, (alpha 4 plus beta 4 not equal to gamma 4) by Cross, James T

    Published in Mathematics magazine (01-04-1993)
    “…  In the Gaussian integers, alpha four plus beta four not equal to gamma four is presented…”
    Get full text
    Magazine Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19